Frontier Biotech's Loxoprofen Sodium Patch Receives Drug Registration Certificate

Regulation
โดย CLS·CN·Read original
Summary · why it matters

Qihe Frontier Biotech Pharmaceutical, a wholly-owned subsidiary of Frontier Biotech, has received the Drug Registration Certificate for Loxoprofen Sodium Patch issued by the National Medical Products Administration, approving the production of this drug.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews